JP2006506097A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006506097A5 JP2006506097A5 JP2004570419A JP2004570419A JP2006506097A5 JP 2006506097 A5 JP2006506097 A5 JP 2006506097A5 JP 2004570419 A JP2004570419 A JP 2004570419A JP 2004570419 A JP2004570419 A JP 2004570419A JP 2006506097 A5 JP2006506097 A5 JP 2006506097A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- conjugate
- virus
- nucleic acid
- host cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 52
- 102000004196 processed proteins & peptides Human genes 0.000 claims 52
- 108090000765 processed proteins & peptides Proteins 0.000 claims 52
- 238000000034 method Methods 0.000 claims 15
- 241000700605 Viruses Species 0.000 claims 14
- 102000039446 nucleic acids Human genes 0.000 claims 11
- 108020004707 nucleic acids Proteins 0.000 claims 11
- 150000007523 nucleic acids Chemical class 0.000 claims 11
- 230000000840 anti-viral effect Effects 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 235000001014 amino acid Nutrition 0.000 claims 7
- 239000013598 vector Substances 0.000 claims 5
- 230000010076 replication Effects 0.000 claims 4
- 125000003277 amino group Chemical group 0.000 claims 3
- 230000001028 anti-proliverative effect Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 230000001580 bacterial effect Effects 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 239000013604 expression vector Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 230000004988 N-glycosylation Effects 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42761202P | 2002-11-18 | 2002-11-18 | |
| US50256003P | 2003-09-12 | 2003-09-12 | |
| PCT/US2003/036682 WO2004046365A2 (en) | 2002-11-18 | 2003-11-17 | Interferon-alpha polypeptides and conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006506097A JP2006506097A (ja) | 2006-02-23 |
| JP2006506097A5 true JP2006506097A5 (enExample) | 2007-01-11 |
Family
ID=32329174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004570419A Pending JP2006506097A (ja) | 2002-11-18 | 2003-11-17 | インターフェロン−αのポリペプチドおよび結合体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20040219131A1 (enExample) |
| EP (1) | EP1565205A4 (enExample) |
| JP (1) | JP2006506097A (enExample) |
| KR (1) | KR20050086498A (enExample) |
| AU (1) | AU2003297285A1 (enExample) |
| BR (1) | BR0316324A (enExample) |
| CA (1) | CA2504267A1 (enExample) |
| IL (1) | IL168049A0 (enExample) |
| MX (1) | MXPA05005263A (enExample) |
| NO (1) | NO20052363L (enExample) |
| NZ (1) | NZ540043A (enExample) |
| RU (1) | RU2005118998A (enExample) |
| WO (1) | WO2004046365A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1141275B1 (en) | 1999-01-05 | 2009-08-12 | Trustees Of Boston University | Improved nucleic acid cloning |
| US7435562B2 (en) | 2000-07-21 | 2008-10-14 | Modular Genetics, Inc. | Modular vector systems |
| US7959910B2 (en) | 2000-07-31 | 2011-06-14 | Biolex Therapeutics, Inc. | C-terminally truncated interferon alpha variants |
| US7611700B2 (en) * | 2002-09-09 | 2009-11-03 | Hanall Pharmaceuticals, Co., Ltd. | Protease resistant modified interferon alpha polypeptides |
| CA2511815A1 (en) * | 2002-12-26 | 2004-07-22 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| WO2004060299A2 (en) | 2002-12-26 | 2004-07-22 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates of interferon-beta with enhanced biological potency |
| WO2004076474A2 (en) * | 2003-02-26 | 2004-09-10 | Intermune, Inc. | Polyethylene glycol modified interferon compositions and methods of use thereof |
| JP5015608B2 (ja) | 2004-01-21 | 2012-08-29 | ネクター セラピューティクス | プロピオン酸末端ポリマーの調製方法 |
| US7318918B2 (en) * | 2004-05-19 | 2008-01-15 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
| JP2008509889A (ja) * | 2004-06-30 | 2008-04-03 | イージェン コーポレーション | ペグ化インターフェロンα−１ｂ |
| US20060024272A1 (en) * | 2004-07-29 | 2006-02-02 | Large Scale Biology Corporation | C-terminally truncated interferon |
| CA2590245A1 (en) | 2004-11-11 | 2006-05-18 | Modular Genetics, Inc. | Ladder assembly and system for generating diversity |
| US9931413B2 (en) * | 2005-04-06 | 2018-04-03 | Ibc Pharmaceuticals, Inc. | Tetrameric cytokines with improved biological activity |
| US20070054360A1 (en) | 2005-05-12 | 2007-03-08 | Zeren Gao | Compositions and methods for modulating immune responses |
| AU2006299901A1 (en) * | 2005-05-18 | 2007-04-19 | Maxygen, Inc. | Evolved interferon-alpha polypeptides |
| KR101470472B1 (ko) * | 2006-09-14 | 2014-12-09 | 메드제닉스 메디칼 이스라엘 리미티드 | 장기 지속형 약물 제형 |
| US9127084B2 (en) | 2006-09-14 | 2015-09-08 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
| US8454948B2 (en) | 2006-09-14 | 2013-06-04 | Medgenics Medical Israel Ltd. | Long lasting drug formulations |
| CN1970572A (zh) * | 2006-12-21 | 2007-05-30 | 北京三元基因工程有限公司 | 干扰素α突变体及其聚乙二醇衍生物 |
| US11535673B2 (en) * | 2007-04-05 | 2022-12-27 | President and Fellows of Harvard CoHege | Chimeric activators: quantitatively designed protein therapeutics and uses thereof |
| US7625555B2 (en) | 2007-06-18 | 2009-12-01 | Novagen Holding Corporation | Recombinant human interferon-like proteins |
| US20130225789A1 (en) * | 2012-02-29 | 2013-08-29 | Yi Sun | Polyethylene Glycol Having Hetero Multiple Functional Groups |
| US20250145680A1 (en) * | 2021-08-18 | 2025-05-08 | Remd Biotherapeutics, Inc. | Novel interferon variants and bifunctional fusion molecules thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610830B1 (en) * | 1980-07-01 | 2003-08-26 | Hoffman-La Roche Inc. | Microbial production of mature human leukocyte interferons |
| US4414150A (en) * | 1980-11-10 | 1983-11-08 | Genentech, Inc. | Hybrid human leukocyte interferons |
| US4801685A (en) * | 1981-08-14 | 1989-01-31 | Hoffmann-La Roche Inc. | Microbial production of mature human leukocyte interferon K and L |
| US4678751A (en) * | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
| IE54592B1 (en) * | 1982-03-08 | 1989-12-06 | Genentech Inc | Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby |
| US6936694B1 (en) * | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
| EP0205404B1 (en) * | 1985-06-11 | 1992-07-15 | Ciba-Geigy Ag | Hybrid interferons |
| US5574138A (en) * | 1993-03-08 | 1996-11-12 | Immunex Corporation | Epithelium-derived T-cell factor |
| US6335160B1 (en) * | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| TW517067B (en) * | 1996-05-31 | 2003-01-11 | Hoffmann La Roche | Interferon conjugates |
| ATE369384T1 (de) * | 1999-05-19 | 2007-08-15 | Emd Lexigen Res Ct Corp | Expression und export von interferon-alpha proteinen als fc fusionsproteine |
| AU8001300A (en) * | 1999-10-07 | 2001-05-10 | Maxygen, Inc. | Ifn-alpha homologues |
| US20020025304A1 (en) * | 2000-06-16 | 2002-02-28 | Croze Edward M. | Novel interferon for the treatment of multiple sclerosis |
| WO2002044197A2 (en) * | 2000-12-01 | 2002-06-06 | Fish Eleanor N | Cytokine receptor binding peptides |
| RU2005118752A (ru) * | 2002-11-15 | 2006-02-10 | Ф.Хоффманн-Ля Рош Аг (Ch) | Позиционные изомеры пэгилированного интерферона l-2а (конъюгата пэг-ifn-l-2а) |
-
2003
- 2003-11-17 WO PCT/US2003/036682 patent/WO2004046365A2/en not_active Ceased
- 2003-11-17 AU AU2003297285A patent/AU2003297285A1/en not_active Abandoned
- 2003-11-17 KR KR1020057008337A patent/KR20050086498A/ko not_active Withdrawn
- 2003-11-17 JP JP2004570419A patent/JP2006506097A/ja active Pending
- 2003-11-17 MX MXPA05005263A patent/MXPA05005263A/es not_active Application Discontinuation
- 2003-11-17 US US10/714,817 patent/US20040219131A1/en not_active Abandoned
- 2003-11-17 EP EP03811632A patent/EP1565205A4/en not_active Withdrawn
- 2003-11-17 CA CA002504267A patent/CA2504267A1/en not_active Abandoned
- 2003-11-17 RU RU2005118998/15A patent/RU2005118998A/ru not_active Application Discontinuation
- 2003-11-17 BR BR0316324-5A patent/BR0316324A/pt not_active Application Discontinuation
- 2003-11-17 NZ NZ540043A patent/NZ540043A/en unknown
-
2005
- 2005-04-14 IL IL168049A patent/IL168049A0/en unknown
- 2005-05-12 NO NO20052363A patent/NO20052363L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006506097A5 (enExample) | ||
| US7528223B2 (en) | Antigens encoded by alternative reading frames from pathogenic viruses | |
| JP2008505985A5 (enExample) | ||
| JP2008507298A5 (enExample) | ||
| JP2642291B2 (ja) | ハイブリド型ヒト白血球インタフェロンをコードするｄｎａ | |
| US8435535B2 (en) | Fusion proteins of HIV regulatory/accessory proteins | |
| JP2013501038A5 (enExample) | ||
| Kozlovska et al. | RNA phage Qβ coat protein as a carrier for foreign epitopes | |
| JP2006187292A5 (enExample) | ||
| US6020167A (en) | Composition used as a therapeutic agent against chronic viral hepatic diseases | |
| JP2002527052A5 (enExample) | ||
| JP2006501825A5 (enExample) | ||
| RU2005118998A (ru) | Полипептиды и конъюгаты альфа-интерферона | |
| JP2008514203A5 (enExample) | ||
| JP2004531242A5 (enExample) | ||
| JP2006518331A5 (enExample) | ||
| KR20030024876A (ko) | 리바비린 함유 백신 및 이것의 사용 방법 | |
| CN102112601B (zh) | 新的融合蛋白及其用于制备针对丙型肝炎的疫苗的用途 | |
| EP3342866B1 (en) | Polypeptide carrier for presenting target polypeptide and uses thereof | |
| JP2018533908A5 (enExample) | ||
| WO1998028004A1 (en) | Hepatitis delta particle containing a fusion protein immunogen | |
| JP2002522512A5 (enExample) | ||
| JP6538071B2 (ja) | 非天然発生のブタ生殖器呼吸器症候群ウイルス（ｐｒｒｓｖ）及び使用する方法 | |
| JP2011521648A5 (enExample) | ||
| JP2011530277A5 (enExample) |